Added to YB: 2024-11-14
Pitch date: 2024-11-14
ECOR [bullish]
electroCore, Inc.
-65.18%
current return
Author Info
@smantel is an ex-sell side analyst with a focus on fundamental research. Follow him on Twitter.
Company Info
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation (“nVNS”) technology platform in the United States, the United Kingdom, and internationally.
Market Cap
$36.9M
Pitch Price
$13.70
Price Target
16.50 (+247%)
Dividend
N/A
EV/EBITDA
-3.08
P/E
-3.21
EV/Sales
1.26
Sector
Health Care Equipment and Supplies
Category
growth
ElectroCore Expands DTC Channels, Projects 3x Revenue Growth Potential by 2025
ECOR: 8th consec record rev qtr, +45.4% YoY. Truvaga DTC sales +147%. Amazon expansion, influencer programs. $2.50 rev per $1 ad spend. VA/DoD growth potential. 30M+ lives covered. Patent protection to 2037. $21.7M net cash. EV $75.2M. '25E $40M rev possible. 3X '25E EV/S = $16.50 PT.
Read full article (2 min)